Scholarlink

Background <p>Eubiosis or dysbiosis of the vaginal microbiome may influence the rate of pregnancy loss and preterm birth, the major cause of neonatal and perinatal mortality worldwide.</p> Methods <p>This was a comparison of two vaginal microbiome studies; one a cohort study and the other a multinational randomised controlled feasibility study. Both studies used cultivation-independent molecular microbiological techniques that together have implications on the risk of pregnancy loss and preterm birth in association with vaginal dysbiosis.</p> Results <p>The cohort study identified a risk-associated vaginal microbiome signature in association with early pregnancy-loss that comprised an increase in the relative abundance of potentially dysbiotic organisms such as <i>Lactobacillus iners</i>,<i> Sneathia</i> and <i>Prevotella</i> spp and a concomitant decrease in the abundance of eubiotic microorganisms such as <i>Lactobacillus crispatus.</i> Convergent evidence across the two studies demonstrated that a synbiotic intervention was able to shift the vaginal microbiome from the signature demonstrated by Skafte-Holm et al., to a decrease in the abundance of <i>Prevotella</i>,<i> Gardnerella</i> and <i>Atopobium</i> spp, while simultaneously increasing the abundance of eubiotic vaginal <i>Lactobacillus</i> spp.</p> Conclusions <p>We concluded that there is convergent evidence across the two studies which might otherwise have gone unnoticed. While neither study was powered to demonstrate clinical endpoints and did not establish causal relationships between microbiome modulation and pregnancy outcomes, when administered regularly, vaginal commensal probiotics in ice-cream were effective in optimizing both the vaginal and intestinal microbiota in pregnant women at increased risk of pregnancy loss, particularly preterm birth. This emphasises the need for adequately powered trials to test whether early pregnancy vaginal microbiome modulation can improve clinical outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The role of the vaginal microbiome in pregnancy loss and preterm birth: a commentary

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月7日

查看全文
  • Ronald F. Lamont,
  • Theda U. P. Bartolomaeus,
  • Leonora S. Borum,
  • Sofia K. Forslund-Startceva,
  • Jan S. Jørgensen

摘要

Background

Eubiosis or dysbiosis of the vaginal microbiome may influence the rate of pregnancy loss and preterm birth, the major cause of neonatal and perinatal mortality worldwide.

Methods

This was a comparison of two vaginal microbiome studies; one a cohort study and the other a multinational randomised controlled feasibility study. Both studies used cultivation-independent molecular microbiological techniques that together have implications on the risk of pregnancy loss and preterm birth in association with vaginal dysbiosis.

Results

The cohort study identified a risk-associated vaginal microbiome signature in association with early pregnancy-loss that comprised an increase in the relative abundance of potentially dysbiotic organisms such as Lactobacillus iners, Sneathia and Prevotella spp and a concomitant decrease in the abundance of eubiotic microorganisms such as Lactobacillus crispatus. Convergent evidence across the two studies demonstrated that a synbiotic intervention was able to shift the vaginal microbiome from the signature demonstrated by Skafte-Holm et al., to a decrease in the abundance of Prevotella, Gardnerella and Atopobium spp, while simultaneously increasing the abundance of eubiotic vaginal Lactobacillus spp.

Conclusions

We concluded that there is convergent evidence across the two studies which might otherwise have gone unnoticed. While neither study was powered to demonstrate clinical endpoints and did not establish causal relationships between microbiome modulation and pregnancy outcomes, when administered regularly, vaginal commensal probiotics in ice-cream were effective in optimizing both the vaginal and intestinal microbiota in pregnant women at increased risk of pregnancy loss, particularly preterm birth. This emphasises the need for adequately powered trials to test whether early pregnancy vaginal microbiome modulation can improve clinical outcomes.